The Liberia Men's Health Screening Program for Ebola virus: win-win-win for survivor, scientist, and public health

Among the most important findings to have emerged from the massive 2013–16 outbreak of Ebola virus disease in west Africa is the delayed clearance of virus from the semen of men who survived the disease1–4 and the consequent risk of sexual transmission of the virus, although this seems to be rare.5 In The Lancet Global Health, Moses J Soka and colleagues6 used data from the largest cohort (n=466) of male survivors reported so far from the Men's Health Screening Program in Liberia to further expand our understanding of this important issue.

Abstract licence: CC BY-NC

1. 4.
   Corrected

   Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea · 2016

11 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.